Can liquids administered through Percutaneous Endoscopic Gastrostomy (PEG) tubes form a fecaloma in patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Liquids administered through PEG tubes cannot directly form a fecaloma, but inadequate management of fluid intake and constipation can increase the risk of fecal impaction. A fecaloma is a large, hardened mass of stool that becomes impacted in the colon or rectum, typically resulting from severe constipation 1. Liquid nutrition and medications given through PEG tubes are absorbed in the small intestine, and while they can contribute to constipation if not properly managed, they do not directly solidify into fecalomas.

Key Considerations for PEG Tube Patients

  • Ensure adequate hydration (1.5-2 liters of water daily through the tube) to prevent constipation 1
  • Include fiber supplements if appropriate to promote regular bowel movements
  • Consider a regular bowel regimen with osmotic laxatives like polyethylene glycol to manage constipation
  • Implement a scheduled toileting routine to establish a regular bowel habit
  • Regular assessment of bowel movements is essential, as early intervention for constipation can prevent the development of fecalomas 1

Managing Constipation in PEG Tube Patients

Patients with PEG tubes may develop constipation due to inadequate fluid intake, certain medications (especially opioids, anticholinergics, and some antidepressants), immobility, or neurological conditions affecting bowel motility 1. It is crucial to monitor bowel movements and adjust the bowel regimen as needed to prevent constipation and reduce the risk of fecal impaction. By prioritizing adequate hydration, fiber intake, and regular bowel movements, healthcare providers can minimize the risk of constipation and fecaloma formation in patients with PEG tubes 1.

From the Research

Fecaloma Formation in Patients with PEG Tubes

  • There is no direct evidence to suggest that liquids can turn into a fecaloma in patients with PEG tubes 2, 3.
  • Fecalomas are typically associated with chronic constipation and are usually found in the rectosigmoid area 4, 5.
  • The formation of a fecaloma is often related to colonic sensorimotor disturbances and pelvic floor dysfunction, rather than the presence of a PEG tube 6.

PEG Tube-Related Complications

  • PEG tubes can be associated with various complications, including tube-related complications and late complications associated with PEG tube use and wound care 2, 3.
  • However, there is no specific evidence to suggest that PEG tubes can cause liquids to turn into a fecaloma 2, 3.

Management of Fecalomas

  • Fecalomas can be treated with conservative methods such as laxatives, enemas, and rectal evacuation 4, 5.
  • In some cases, surgical intervention may be necessary to remove the fecaloma 4.
  • The use of polyethylene glycol (PEG) and sodium picosulphate (SPS) has been shown to be effective in treating fecal impaction in children 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

PEG tubes: dealing with complications.

Nursing times, 2014

Research

Ileal Fecaloma Presenting with Small Bowel Obstruction.

Pediatric gastroenterology, hepatology & nutrition, 2015

Research

Treatment of fecal impaction in children using combined polyethylene glycol and sodium picosulphate.

JGH open : an open access journal of gastroenterology and hepatology, 2018

Related Questions

What cough medications can be administered through a Percutaneous Endoscopic Gastrostomy (PEG) tube?
Should a 52-year-old male with new-onset constipation and a normal colonoscopy start linacotide (linaclotide) or undergo imaging?
How to manage a patient with constipation and urinary retention?
How to manage constipation in a 7 kg girl?
What is the appropriate treatment for a 43-year-old male patient presenting with complaints of bloating and constipation, who reports being irregular, and is started on Fiber lax (psyllium) 625 mg?
What is the recommended interval for repeating Human Immunodeficiency Virus (HIV) testing in individuals with high-risk behaviors?
What are the differential diagnoses for a patient with persistently elevated Immunoglobulin G4 (IgG4) levels, normocytic anemia, and chronic, non-healing skin lesions with distinctive firm, white borders, in the context of normal immunoglobulin A (IgA), immunoglobulin E (IgE), and immunoglobulin M (IgM) levels, and unremarkable complete metabolic panel (CMP) and complete blood count (CBC) with differential results?
What is the recommended timeframe for repeating Human Immunodeficiency Virus (HIV) testing in individuals with high-risk behaviors who have previously tested negative?
What are the differential diagnoses for a patient with persistently elevated Immunoglobulin G4 (IgG4) levels, normocytic anemia, and chronic skin lesions with a distinctive appearance, characterized by a firm, slightly raised, whitish border and circular shape, that are refractory to treatment with broad-spectrum antibiotics, including Bactroban (mupirocin), and topical steroids, and have undergone punch biopsies showing extensive fibrosis and a significant amount of fibroblasts?
Does inflammation reduce the effectiveness of local anesthesia?
Is chronic appendicitis a valid medical diagnosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.